New semaglutide drugs Ozempic and Wegovy help people lose weight by mimicking key hunger hormones. But when people stop taking the drugs, they often regain much of what they lost. A doctor taking the ...

Please provide your email address to receive an email when new articles are posted on . Guselkumab 200 mg every 4 weeks was more beneficial in patients with high disease activity and severity than 100 ...

Credit: Novo Nordisk Wegovy is a glucagon-like peptide-1 receptor agonist. The prescribing information for Wegovy (semaglutide) has been updated to include new information related to maintenance ...

More than half of Ozempic users prescribed the drug for obesity alone are stopping or reducing their doses within a year, ...

Credit: Eisai and Biogen. The SC formulation is supplied as a 360mg/1.8mL single-dose prefilled autoinjector. To help support patients with at-home administration, Eisai and Biogen have launched the ...

This is the third FDA approval for Omvoh this year, following approvals for Crohn's disease and a citrate-free formulation INDIANAPOLIS, Oct. 27, 2025 /PRNewswire/ -- Eli Lilly and Company (LLY) ...

With several anti-amyloid antibodies now proven to clear plaque from the human brain, researchers are turning their attention to fine-tuning immunotherapy for Alzheimer’s disease. At the 16th ...

Ultomiris (ravulizumab-cwvz) is a brand-name drug prescribed for certain autoimmune conditions. Ultomiris is given as an intravenous (IV) infusion by a healthcare professional. The drug’s dosing ...